February 2025 FDA Recall Drug by Nephron Sterile Compounding Center Llc
D-0257-2025 - Lack of Assurance of Sterility

This Class II drug recall was voluntarily initiated by Nephron Sterile Compounding Center Llc on February 10, 2025 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0257-2025

Reason for Recall
Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.
Initiated
02-10-2025
Reported
03-19-2025
Quantity
4,190 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nephron Sterile Compounding Center LLC
Sodium Chloride Injection 9%, USP, 500 mL, Single-Dose IV Bottle, Rx Only, nephron, 503B outsourcing facility, West Columbia, SC 29172, NDC: 69374-334-50

Batch or Lot Expiration Information

Lot# NA4008B, exp. date 03/03/2025
Lot# NA4005B & NA4005E, exp. date 02/20/2025